NCT01445340 2019-12-17Topical Romidepsin to Treat Early-Stage Cutaneous T-Cell LymphomaNational Institutes of Health Clinical Center (CC)Phase 1 Terminated6 enrolled
NCT01353664 2019-11-25A Rollover Study for Patients Who Participated in Other Romidepsin ProtocolsCelgenePhase 2 Completed19 enrolled 12 charts